Quarterly Results

202605 Results Summary

Revenue

The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Operating Profit

Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

PBDT

PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Profit Before Tax

Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.

Net Profit

Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Company News

More

Earnings

CategoryQ4 FY25-26Q4 FY24-25Change %FY25-26FY24-25Change %
Total Revenue1,811.571,720.305.316,812.905,553.9622.67
Expenses1,299.461,299.70-0.025,035.194,498.6811.93
Other Income11.8058.57-79.8554.9575.10-26.83
Operating Profit512.11420.6021.761,832.661,130.3862.13
Depreciation122.10110.4310.57480.05430.0911.62
Interest40.4456.40-28.30170.73216.00-20.96
Profit Before Tax361.55311.2416.161,181.88484.29144.04
Tax79.4678.471.26297.52156.9089.62
Net Profit282.09232.7721.19889.85354.41151.08
CategoryQ4 FY25-26Q3 FY25-26Change %
Total Revenue1,811.571,778.291.87
Expenses1,299.461,298.080.11
Other Income11.805.76104.86
Operating Profit512.11480.216.64
Depreciation122.10120.621.23
Interest40.4438.794.25
Profit Before Tax361.55325.3311.13
Tax79.4673.458.18
Net Profit282.09251.8811.99

Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Financial Reports

Data not available.

Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Data Not Found

Corporate Information

Company News

Stocks to buy: Graphite India, Laurus Labs, Tata Steel are on analyst radar

Stocks to buy today, February 26, 2026: Kunal Kamble of Bonanza Portfolio recommends buying Laurus Labs, Tata Steel, and Graphite India; here's why

Updated On: 26 Feb 2026 | 8:16 AM IST

Indian CRDMO market to outpace APAC; HDFC Sec starts coverage on top firms

While HDFC Securities has assigned a 'Buy' rating to Divi's Labs, Sai Life Sciences, and Piramal Pharma, it has given an 'Add' rating to Anthem BioSciences and a 'Reduce' rating to Laurus Labs

Updated On: 09 Jan 2026 | 11:20 AM IST

Pharma index hits 52-week high; Glenmark, Lupin rally 3% in subdued market

In the past two trading days, the Nifty Pharma index has rallied 3.3 per cent, as compared to 0.41 per cent decline in the Nifty 50.

Updated On: 07 Jan 2026 | 12:14 PM IST

Laurus zooms 82% so far in 2025; set for best yearly performance in 5 years

The stock hit a new high of ₹1,095, appreciated 117% from its 52-week low of ₹504.30 touched on January 28, 2025.

Updated On: 30 Dec 2025 | 3:07 PM IST

MCX, TVS Motor, Mahindra Finance, 8 others from BSE500 hit record highs

Among others - Ashok Leyland, India Cements, Laurus Labs, Federal Bank, Shriram Finance, Hindalco, Vedanta and NALCO shares were also trading at life-time highs in Monday's trading session.

Updated On: 22 Dec 2025 | 1:40 PM IST

Laurus Labs zooms 73% in 2025, hits new high; what's driving pharma stock?

Laurus Labs management said the fundamentals of the company's business remain strong, with sustained growth momentum in the Contract Development and Manufacturing Organization and Generic business.

Updated On: 19 Dec 2025 | 10:14 AM IST
More